XML 48 R25.htm IDEA: XBRL DOCUMENT
v3.20.1

Organization and Description of Business - Narrative (Details) $ / shares in Units, shares in Thousands |  |  | 3 Months Ended | 12 Months Ended
--- | --- | --- | --- | ---
May 07, 2019 USD ($) $ / shares shares | Apr. 09, 2018 | Mar. 31, 2020 USD ($) delivery financial_institution diseaseAreas segment $ / shares | Sep. 30, 2019 USD ($) | Jun. 30, 2019 USD ($) | Mar. 31, 2019 USD ($) $ / shares | Dec. 31, 2019 USD ($)
Cash and Cash Equivalents [Line Items] |  |  |  |  |  |  |
Number of operating segments | segment |  |  | 1 |  |  |  |
Number of disease areas with genomic testing | diseaseAreas |  |  | 4 |  |  |  |
Prior period reclassification adjustment |  |  |  |  |  | $ 212,000 |
Number of shares issued and sold (in shares) | shares | 6,325 |  |  |  |  |  |
Price per share (in usd per share) | $ / shares | $ 23.25 |  |  |  |  |  |
Proceeds from issuance of common stock | $ 137,800,000 |  |  |  |  |  |
Stock issuance costs | $ 9,200,000 |  |  |  |  |  |
Percent of principal amount needed to be collateralized by U.S. treasury and agency securities |  |  | 102.00% |  |  |  |
Number of major financial institutions with which the company's cash and cash equivalents are deposited (in financial institutions) | financial_institution |  |  | 1 |  |  |  |
Restricted cash |  |  | $ 603,000 |  |  |  | $ 603,000
Loss from operations |  |  | $ (12,200,000) |  |  | $ (2,067,000) |
Net income (loss) per common share, basic and diluted (in usd per share) | $ / shares |  |  | $ (0.24) |  |  | $ (0.05) |
Number of tissue sample deliveries (in deliveries) | delivery |  |  | 0 |  |  |  |
Revenue |  |  | $ 31,122,000 |  |  | $ 29,529,000 |
Right-of-use assets - operating lease |  |  | 8,576,000 |  |  |  | 8,808,000
Operating lease, liability |  |  | 12,582,000 |  |  |  |
Headquarters and laboratory facilities, South San Francisco, lease signed April 2015 |  |  |  |  |  |  |
Cash and Cash Equivalents [Line Items] |  |  |  |  |  |  |
Restricted cash |  |  | 603,000 |  |  |  | 603,000
Biopharmaceutical Company |  |  |  |  |  |  |
Cash and Cash Equivalents [Line Items] |  |  |  |  |  |  |
Deferred revenue |  |  | 0 |  |  |  | 0
Tissue Samples |  |  |  |  |  |  |
Cash and Cash Equivalents [Line Items] |  |  |  |  |  |  |
Contract with customer, revenue recognized |  |  | 90,000 |  |  |  |
Contract agreement term |  | 1 year |  |  |  |  |
Automatic renewal period of contract agreement |  | 1 year |  |  |  |  |
Termination period |  | 90 days |  |  |  |  |
Revenue |  |  | 3,409,000 |  |  | 0 |
Other Services |  |  |  |  |  |  |
Cash and Cash Equivalents [Line Items] |  |  |  |  |  |  |
Contract with customer, revenue recognized |  |  |  | $ 250,000 | $ 250,000 | 250,000 |
Testing |  |  |  |  |  |  |
Cash and Cash Equivalents [Line Items] |  |  |  |  |  |  |
Revenue |  |  | 26,991,000 |  |  | 25,389,000 |
Write-down of supplies |  |  | 1,100,000 |  |  |  |
Testing | Revenue recognition |  |  |  |  |  |  |
Cash and Cash Equivalents [Line Items] |  |  |  |  |  |  |
Loss from operations |  |  |  |  |  | $ 600,000 |
Net income (loss) per common share, basic and diluted (in usd per share) | $ / shares |  |  |  |  |  | $ 0.02 |
Revenue |  |  |  |  |  | $ 600,000 |
Biopharmaceutical |  |  |  |  |  |  |
Cash and Cash Equivalents [Line Items] |  |  |  |  |  |  |
Revenue |  |  | 722,000 |  |  | 4,140,000 |
Johnson & Johnson |  |  |  |  |  |  |
Cash and Cash Equivalents [Line Items] |  |  |  |  |  |  |
Receivable from agreement |  |  | 7,000,000.0 |  |  |  |
Contractual proceeds |  |  | $ 13,000,000.0 |  |  |  |
Percentage of net cash collections, fee |  |  | 1.00% |  |  |  |
Accounts Receivable, after Allowance for Credit Loss |  |  | $ 0 |  |  |  | 2,000,000.0
Johnson & Johnson | Percepta v.2 |  |  |  |  |  |  |
Cash and Cash Equivalents [Line Items] |  |  |  |  |  |  |
Revenue |  |  | 0 |  |  | $ 3,800,000 | 7,000,000.0
Johnson & Johnson | NasaRISK |  |  |  |  |  |  |
Cash and Cash Equivalents [Line Items] |  |  |  |  |  |  |
Revenue |  |  |  |  |  |  | $ 4,000,000.0
AstraZeneca |  |  |  |  |  |  |
Cash and Cash Equivalents [Line Items] |  |  |  |  |  |  |
Revenue |  |  | 100,000 |  |  |  |
Accounts Receivable, after Allowance for Credit Loss |  |  | 100,000 |  |  |  |
Biopharmaceutical Company |  |  |  |  |  |  |
Cash and Cash Equivalents [Line Items] |  |  |  |  |  |  |
Contract agreement, amount |  |  | 500,000 |  |  |  |
Biopharmaceutical Company | Biopharmaceutical |  |  |  |  |  |  |
Cash and Cash Equivalents [Line Items] |  |  |  |  |  |  |
Revenue |  |  | $ 300,000 |  |  |  |
Over-Allotment Option |  |  |  |  |  |  |
Cash and Cash Equivalents [Line Items] |  |  |  |  |  |  |
Number of shares issued and sold (in shares) | shares | 825 |  |  |  |  |  |

X
- Definition Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(3)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(5)) -URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910 + Details
Name: | us-gaap_AccountsReceivableNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_CashAndCashEquivalentsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=118944033&loc=SL49130531-203044 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 8 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=118944033&loc=SL49130532-203044 + Details
Name: | us-gaap_ContractWithCustomerLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 8 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045 + Details
Name: | us-gaap_ContractWithCustomerLiabilityRevenueRecognized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256 + Details
Name: | us-gaap_EarningsPerShareBasicAndDiluted
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314 + Details
Name: | us-gaap_InventoryWriteDown
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. + References No definition available. + Details
Name: | us-gaap_NumberOfOperatingSegments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References No definition available. + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Present value of lessee's discounted obligation for lease payments from operating lease. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 45 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977 + Details
Name: | us-gaap_OperatingLeaseLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of lessee's right to use underlying asset under operating lease. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977 + Details
Name: | us-gaap_OperatingLeaseRightOfUseAsset
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The cash outflow for cost incurred directly with the issuance of an equity security. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585 + Details
Name: | us-gaap_PaymentsOfStockIssuanceCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of a reclassification adjustment made to prior period financial statement amounts. + References No definition available. + Details
Name: | us-gaap_PriorPeriodReclassificationAdjustment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash inflow from the additional capital contribution to the entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6812-107765 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(17)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 954 -SubTopic 210 -Section 45 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=116631420&loc=SL116631458-115580 + Details
Name: | us-gaap_RestrictedCashAndCashEquivalentsNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Automatic Renewal Period, Contract Agreement + References No definition available. + Details
Name: | vcyt_AutomaticRenewalPeriodContractAgreement
Namespace Prefix: | vcyt_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Contract Agreement, Amount + References No definition available. + Details
Name: | vcyt_ContractAgreementAmount
Namespace Prefix: | vcyt_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Contract Agreement, Conditional Additional Receivable + References No definition available. + Details
Name: | vcyt_ContractAgreementConditionalAdditionalReceivable
Namespace Prefix: | vcyt_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Contract Agreement, Fee, Percentage Of Cash Collections + References No definition available. + Details
Name: | vcyt_ContractAgreementFeePercentageOfCashCollections
Namespace Prefix: | vcyt_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Contract Agreement, Receivable For Services + References No definition available. + Details
Name: | vcyt_ContractAgreementReceivableForServices
Namespace Prefix: | vcyt_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of Disease Areas With Genomic Testing + References No definition available. + Details
Name: | vcyt_NumberOfDiseaseAreasWithGenomicTesting
Namespace Prefix: | vcyt_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the number of major financial institutions, with which cash and cash equivalents are deposited by the entity. + References No definition available. + Details
Name: | vcyt_NumberOfMajorFinancialInstitutionsWithWhichCashAndCashEquivalentsDeposited
Namespace Prefix: | vcyt_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of Tissue Sample Deliveries + References No definition available. + Details
Name: | vcyt_NumberofTissueSampleDeliveries
Namespace Prefix: | vcyt_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percent of Principal Amount Needed To Be Collateralized By U.S. Treasury and Agency Securities + References No definition available. + Details
Name: | vcyt_PercentofPrincipalAmountNeededToBeCollateralizedByU.S.TreasuryandAgencySecurities
Namespace Prefix: | vcyt_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Term, Contract Agreement + References No definition available. + Details
Name: | vcyt_TermContractAgreement
Namespace Prefix: | vcyt_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Termination Period, Contract Agreement + References No definition available. + Details
Name: | vcyt_TerminationPeriodContractAgreement
Namespace Prefix: | vcyt_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_StatementGeographicalAxis=vcyt_HeadquartersAndLaboratoryFacilitiesSouthSanFranciscoLeaseTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=vcyt_BiopharmaceuticalCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_ProductMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_ServiceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=vcyt_TestingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ChangeInAccountingEstimateByTypeAxis=vcyt_RevenueRecognitionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=vcyt_BiopharmaceuticalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=vcyt_JohnsonJohnsonServicesInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=vcyt_PerceptaV2Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=vcyt_NasaRISKMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=vcyt_AstraZenecaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=vcyt_BiopharmaceuticalCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |